Fresenius became aware this patient with end stage renal disease (esrd) on continuous cyclic peritoneal dialysis [cc(pd)] for renal replacement therapy (rrt) experienced two pd catheter (not fresenius products) events.The first event occurred on (b)(6) 2020 (initial encounter), and the second on (b)(6)2021 (subsequent encounter).Follow-up communication from the patient's pd registered nurse (porn) revealed the patient was not hospitalized for either event.The porn reported on (b)(6)2020 drainage was noted coming from the patient's pd catheter exit site.The porn stated it was "not an infection," and the patient was successfully treated with oral and topical antibiotics (drug, dose, duration, frequency not provided).Additionally, the (b)(6)2021 event date was reportedly an evaluation by a surgeon to inspect the patient's pd catheter for a "tunnel infection." it was reported all tests were negative.Based on the available information, there is no allegation or objective evidence indicating a serious injury, patient death, or other serious adverse event(s) related to a fresenius device(s) or product(s) occurred.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|